PRKAA2 and prostate carcinoma: Testosterone activates cooperative mechanisms interlinking transcription and transduction signaling pathways involving AMPK and peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) to transcriptionally regulate glucose metabolism in prostate cancer [33, 34] and skeletal muscle cells [34].